5 ms·
"But Meisel said he was convinced by a patient survey Johnson & Johnson conducted. 'We don’t take the patient voice into account enough,' he said." I suppose i
by rdiddly 8y ago
"But Meisel said he was convinced by a patient survey Johnson & Johnson conducted. 'We don’t take the patient voice into account enough,' he said."
I suppose it didn't occur to him that the company trying to get their drug approved might not have taken the patient voice into account enough either? Or maybe under-reported certain patient voices? (The adverse ones. Hey, it's not like it has never happened. At least take a closer look!)
- torrance 8y agoThis. Evidence and studies like this should not be done by the company itself. The OxyContin claims about low addictiveness should be a timely reminder for independent clinical studies. Reading that set off alarm bells for me.
- billybaldwin3 8y agoDon't say "This."
- DanBC 8y agoThey said the same thing about Prozac -- that it made you better than well and that current licencing which restricted use to people with illness was denying people access to this wonder drug. SSRIs are useful meds, but they're not miracles.
- rincebrain 8y agoThe two are not mutually exclusive. Opiates, for example, do solve certain problems very effectively. That doesn't mean they're not extremely abusable and dangerous to use without proper caution. Frankly, it's also going to be hard to distinguish between some types of addictive behaviors and people desperately seeking to avoid sinking back into the morass of their mental states prior to effective treatment.